Amicus Therapeutics (FOLD) Misses Q4 EPS by 6c

Amicus Therapeutics (NASDAQ: FOLD) reported Q4 EPS of ($0.24), $0.06 worse than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Amicus Therapeutics (FOLD) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Lockheed Martin frontrunner for $3.5B Ultra Maritime deal, sources say - FT
• Six Flags names Mark Pauls as chief operating officer